MYGN
Myriad Genetics Inc
stockNASDAQ
At CloseOct 20, 2026 3:59:57 PM EDT
5.55USD+31.710%(+1.34)23,848,730
Pre-marketOct 20, 2026 9:29:30 AM EDT
5.31USD+26.128%(+1.10)
After-hoursOct 20, 2026 4:15:30 PM EDT
5.60USD+0.992%(+0.06)
MYGN Financials
In Q2 FY 2026 (ended ), Myriad Genetics Inc (MYGN) reported revenue of $190.7M, net income of −$43.2M, operating cash flow of −$8.3M, and assets of $638.9M.
Loading financial statements…